A study to assess the cardiovascular disease risk in Indian patients
- Conditions
- Health Condition 1: I52- Other heart disorders in diseasesclassified elsewhere
- Registration Number
- CTRI/2024/02/062577
- Lead Sponsor
- Sun Pharma Laboratories Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Patients of either sex between 20-79 years of age
Patients with SBP between 90-200 mmHg
Patients with DBP between 60-130 mmHg
Patients with TC between 130-320 mgdL
Patients with HDL cholesterol between 20-100 mgdL
Patients with data on the history of diabetes (Yes No)
Patients with data on smoking status (current former never)
Patients with data on hypertension treatment (Yes no)
Patients with LDL between 30-300 mgdL
Patients with data on statin therapy (Yes No)
Patients with data on aspirin therapy (Yes No)
Patients with current ASCVD and history of ASCVD (i.e. CHD, such as myocardial infarction, angina, and coronary artery stenosis; Cerebrovascular disease, such as a transient ischemic attack, ischemic stroke, and carotid artery stenosis; Peripheral artery disease, such as claudication; Aortic atherosclerotic disease, such as abdominal aortic aneurysm and descending thoracic aneurysm).
Patients with incomplete medical records with respect to the required study parameters
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method